RB1-mediated cell-autonomous and host-dependent oncosuppressor mechanisms in radiation-induced osteosarcoma

por Kansara, Maya, Thomas, David M
Publicado 2014

The life history of neochromosomes revealed

por Papenfuss, Anthony T, Thomas, David M
Publicado en Mol Cell Oncol (2015)

Inherited and de novo germline TP53 mutations in adult-onset sarcoma

por Thomas, David M, Ballinger, Mandy L
Publicado 2012

Molecular pathogenesis and targeted therapeutics in Ewing sarcoma/primitive neuroectodermal tumours

por Kelleher, Fergal C, Thomas, David M
Publicado 2012

Functional Analysis of the C2A Domain of Synaptotagmin 1: Implications for Calcium-Regulated Secretion

por Thomas, David M., Elferink, Lisa A.
Publicado en J Neurosci (1998)

Liposarcoma: Molecular Genetics and Therapeutics

por Conyers, Rachel, Young, Sophie, Thomas, David M.
Publicado 2011

Hereditary and environmental epidemiology of sarcomas

por Thomas, David M, Savage, Sharon A, Bond, Gareth L
Publicado 2012

Nucleus Accumbens Invulnerability to Methamphetamine Neurotoxicity

por Kuhn, Donald M., Angoa-Pérez, Mariana, Thomas, David M.
Publicado en ILAR J (2011)

Locally Aggressive Connective Tissue Tumors

por Gounder, Mrinal M., Thomas, David M., Tap, William D.
Publicado en J Clin Oncol (2018)

Dopamine Disposition in the Presynaptic Process Regulates the Severity of Methamphetamine-induced Neurotoxicity

por KUHN, DONALD M., FRANCESCUTTI-VERBEEM, DINA M., THOMAS, DAVID M.
Publicado 2008

The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity

por Thomas, David M., Francescutti-Verbeem, Dina M., Kuhn, Donald M.
Publicado 2007

Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling

por Thomas, David M., Francescutti-Verbeem, Dina M., Kuhn, Donald M.
Publicado 2008

Increases in cytoplasmic dopamine compromise the normal resistance of the nucleus accumbens to methamphetamine neurotoxicity

por Thomas, David M., Francescutti-Verbeem, Dina M., Kuhnt, Donald M.
Publicado en J Neurochem (2009)

Functional and Biochemical Analysis of the C2 Domains of Synaptotagmin IV

por Thomas, David M., Ferguson, Gregory D., Herschman, Harvey R., Elferink, Lisa A.
Publicado 1999

PPARγ-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma

por Chaffer, Christine L, Thomas, David M, Thompson, Erik W, Williams, Elizabeth D
Publicado 2006

High resolution melting analysis for the rapid and sensitive detection of mutations in clinical samples: KRAS codon 12 and 13 mutations in non-small cell lung cancer

por Krypuy, Michael, Newnham, Genni M, Thomas, David M, Conron, Matthew, Dobrovic, Alexander
Publicado 2006

Targeting the p53 Pathway in Ewing Sarcoma

por Neilsen, Paul M., Pishas, Kathleen I., Callen, David F., Thomas, David M.
Publicado 2011

Suicide Assessment and Management Team-Based Learning Module

por Lerchenfeldt, Sarah, Kamel-ElSayed, Suzan, Patino, Gustavo, Thomas, David M., Wagner, Jolyn
Publicado en MedEdPORTAL (2020)

Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma

por Paget, Christophe, Duret, Helene, Ngiow, Shin Foong, Kansara, Maya, Thomas, David M., Smyth, Mark J.
Publicado 2012

Intra-patient dose escalation in Ewing’s sarcoma treated with vincristine, doxorubicin, cyclophosphamide alternating with ifosfamide and etoposide: a retrospective review

por Lewin, Jeremy, Wieringa, Samantha, Collins, Marnie, Desai, Jayesh, Orme, Lisa, Lingaratnam, Senthil, Thomas, David M
Publicado 2013